lomefloxacin and netilmicin

lomefloxacin has been researched along with netilmicin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Canepari, P; Cornaglia, G; Fontana, R; Ligozzi, M; Pelosi, E	1

Other Studies

2 other study(ies) available for lomefloxacin and netilmicin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:2 Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Enterobacteriaceae; Fluoroquinolones; Lactams; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Netilmicin; Quinolones; Staphylococcus; Streptococcus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1989

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.

Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:2

Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Enterobacteriaceae; Fluoroquinolones; Lactams; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Netilmicin; Quinolones; Staphylococcus; Streptococcus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1989